For the last reported quarter, Levi Strauss came out with earnings of $0.38 per share versus the Zacks Consensus Estimate of $0.28 per share, representing a surprise of 35.71%.

David Jedrzejek, SVP and General Counsel at Levi Strauss & Co (NYSE: LEVI), sold 461 shares of Class A Common Stock on June 23, 2025, at a price of $18.00, totaling $8,298.

Levi Strauss & Co. (NYSE: LEVI) will host a conference call to discuss the company’s financial results for the second quarter ended June 1, 2025. The call will be held on Thursday, July 10, 2025 ...

Levi Strauss & Co. (NYSE: LEVI) will host a conference call to discuss the company’s financial results for the second quarter ended June 1, 2025. The call will be held on Thursday, July 10, 2025 ...

For the last reported quarter, it was expected that Levi Strauss would post earnings of $0.28 per share when it actually produced earnings of $0.38, delivering a surprise of +35.71%.

Levi Strauss & Co. Cl A Annual cash flow by MarketWatch. View LEVI net cash flow, operating cash flow, operating expenses and cash dividends.

Yearly Estimates 2024202520262027 High–1.551.851.88 Low–1.221.251.28 Average1.231.271.441.56 LEVI will report Q2 2025 earnings on 07/03/2025 ...

John A. Squires, President Donald Trump’s nominee to run the US Patent and Trademark Office, was voted out of the Senate Judiciary Committee by a 20-2 vote. Senators voted to advance Squires ...

Litigators Blair Jacobs, Christina Ondrick and John Holley are moving from a firm that posted $764,000 in profits per equity partner in 2024 to one that posted $3.44 million in PEP.

Levi Strauss (LEVI) closed at $17.33 in the latest trading session, marking a -1.25% move from the prior day. The stock fell short of the S&P 500, which registered a loss of 0.27% for the day. The ...

Patent lawyers are racing to adapt how they draft and defend drug-device patents after a court ruling reshaped the FDA’s registry that brand-name companies use to fend off generic competition. The ...